Research Progress on Nasal Delivery of siRNA Nanocarrier Systems for the Treatment of Neurodegenerative Diseases
The treatment of central nervous system (CNS) diseases faces huge challenges, mainly due to the blood–brain barrier (BBB) restricting drug delivery, which leads to many potential treatment methods being unable to effectively reach the target area. In recent years, nasal administration has received e...
שמור ב:
| Principais autores: | , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI AG
2025-10-01
|
| סדרה: | Pharmaceutics |
| נושאים: | |
| גישה מקוונת: | https://www.mdpi.com/1999-4923/17/11/1407 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
